- Investing Ideas
- Belgian Pharmaceuticals & Biotech Big Green Snowflakes
Belgian Pharmaceuticals & Biotech Big Green Snowflakes
Results
7
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
7 companies
argenx
Market Cap: €56.1b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€897.60
7D
2.3%
1Y
47.7%
UCB
Market Cap: €42.1b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€221.00
7D
1.5%
1Y
9.8%
Celyad Oncology
Market Cap: €11.7m
A biotechnology company, focuses on unlocking the potential of its intellectual property.
CYAD
€0.26
7D
-4.4%
1Y
-20.9%
Hyloris Pharmaceuticals
Market Cap: €122.9m
Operates as a specialty pharmaceutical company in Belgium, the United States, Europe, the Middle East, Africa, and Asia-Pacific.
HYL
€4.39
7D
-2.4%
1Y
-32.7%
Financière de Tubize
Market Cap: €8.4b
Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium.
TUB
€189.40
7D
2.5%
1Y
16.6%
Oxurion
Market Cap: €266.1k
A biopharmaceutical company, develops medicines for vascular retinal disorder in Belgium.
OXUR
€0.003
7D
7.1%
1Y
-87.0%
BioSenic
Market Cap: €1.3m
A biotechnology company, develops cell therapy products and treatments for autoimmune and inflammatory diseases in Belgium and France.
BIOS
€0.002
7D
0%
1Y
-28.6%